CN100400094C - Traditional Chinese medicine for treating hepatitis B and its preparing process - Google Patents
Traditional Chinese medicine for treating hepatitis B and its preparing process Download PDFInfo
- Publication number
- CN100400094C CN100400094C CNB2006101286482A CN200610128648A CN100400094C CN 100400094 C CN100400094 C CN 100400094C CN B2006101286482 A CNB2006101286482 A CN B2006101286482A CN 200610128648 A CN200610128648 A CN 200610128648A CN 100400094 C CN100400094 C CN 100400094C
- Authority
- CN
- China
- Prior art keywords
- herba
- radix
- hepatitis
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese preparation for treating hepatitis B and process for preparation, wherein the raw materials include rhubarb horsetails, barbat skullcap, flavescent sophora root, artemisia capillaris thumb, herb of stringy stonecrop, oldenlandia, Canton love-pea vine, poria cocos, isatic root, Hypericum japonicum Thunb., paris rhizome, lysimachia christinae, leeches, dried body of ground beetle, giant knotweed rhizome, cudrania root, silybum mariamum, schisandra fruit, curcuma aromatica and licorice root.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of hepatitis B and preparation method thereof.
Background technology
The disease that chronic viral hepatitis B is that a kind of many internal organs are got involved, immunologic hypofunction, pathogenesis complexity, the long refractory of the course of disease are healed is one of main predisposing factors of liver cirrhosis and hepatocarcinoma.
At present, the medicine that is used for the treatment of hepatitis B exist the course of treatment long, expense is high and the patient's body situation is required high defective.
Summary of the invention
For solve the medicine that is used for the treatment of hepatitis B at present exist the course of treatment long, expense is high and the patient's body situation is required the problem of high defective, the invention provides a kind of Chinese medicine for the treatment of hepatitis B.
Technical scheme of the present invention is as follows:
The invention provides a kind of Chinese medicine for the treatment of hepatitis B, crude drug and the parts by weight thereof of forming its effective active ingredient are as follows:
Radix Et Rhizoma Rhei 20-40; Herba Portulacae Grandiflorae 40-60; Radix Sophorae Flavescentis 40-60; Herba Artemisiae Scopariae 40-60; Herba Sedi 80-110; Herba Hedyotidis Diffusae 80-110; Herba Abri 80-110; Kummerowia striata (Thunb.) Schindl 80-110; Rhizoma Smilacis Glabrae 80-110; Radix Isatidis 80-110; Herba Hyperici Japonici 80-110; Rhizoma Paridis 80-110; Herba Lysimachiae 80-110; Hirudo 80-110; Eupolyphaga 80-110; Rhizoma Polygoni Cuspidati 40-60; Radix Cudraniae 80-110; Herba Silybi mariani 80-110; Fructus Schisandrae Chinensis 40-60; Radix Curcumae 40-60; Radix Glycyrrhizae 40-60.
As prioritization scheme, the Chinese medicine of treatment hepatitis B provided by the present invention, crude drug and the parts by weight thereof of forming its effective active ingredient are as follows:
Radix Et Rhizoma Rhei 30; Herba Portulacae Grandiflorae 50; Radix Sophorae Flavescentis 50; Herba Artemisiae Scopariae 50; Herba Sedi 100; Herba Hedyotidis Diffusae 100; Herba Abri 100; Kummerowia striata (Thunb.) Schindl 100; Rhizoma Smilacis Glabrae 100; Radix Isatidis 100; Herba Hyperici Japonici 100; Rhizoma Paridis 100; Herba Lysimachiae 100; Hirudo 100; Eupolyphaga 100; Rhizoma Polygoni Cuspidati 50; Radix Cudraniae 100; Herba Silybi mariani 100; Fructus Schisandrae Chinensis 50; Radix Curcumae 50; Radix Glycyrrhizae 50.
The present invention also provides the preparation method of Chinese medicine of above-mentioned treatment hepatitis B as follows:
The crude drug of described parts by weight is mixed pulverizing, make pharmaceutically acceptable pharmaceutical dosage form.
The using method of the Chinese medicine of treatment hepatitis B provided by the present invention is as follows:
Every day three times, each 5-10 gram.
The technique effect that the present invention realized is as follows:
The Chinese medicine of treatment hepatitis B provided by the present invention can be used for the treatment of hepatitis B small three positive and hepatitis B great three positive HBsAg (+), HBeAg (+) and the immunologic tolerance phase hepatitis B virus duplication person of enlivening, short treating period, and the effective percentage height, and also toxic and side effects is little, and expense is low.
The specific embodiment
The side of the Chinese medicine of treatment hepatitis B provided by the present invention separates as follows:
The Radix Et Rhizoma Rhei bitter in the mouth is cold, GUIXIN, liver, spleen, stomach warp, have assault fortified position, intestinal stasis relieving, removing heat from blood, blood circulation promoting and blood stasis dispelling, promoting the function of the gallbladder to alleviate jaundice, pathogenic fire purging removing blood stasis and the function of stimulating the menstrual flow.The hard difficulty of hepatitis B virus shell is broken, and this prescription water distribution trematodiasis, eupolyphaga, Radix Cudraniae, the Radix Curcumae blood circulation promoting and blood stasis dispelling of assaulting fortified position penetrates viral shell and virus discharged lead in the blood, with Radix Sophorae Flavescentis, Radix Isatidis, Herba Hyperici Japonici, Herba Abri, Kummerowia striata (Thunb.) Schindl heat-clearing and toxic substances removing.Be equipped with Herba Artemisiae Scopariae, Rhizoma Polygoni Cuspidati, Herba Sedi, Herba Lysimachiae promoting diuresis to eliminate damp pathogen.Be equipped with Rhizoma Paridis, Rhizoma Smilacis Glabrae, Herba Hedyotidis Diffusae, Herba Portulacae Grandiflorae booster immunization ability again.Herba Silybi mariani has tangible liver protection function, and Fructus Schisandrae Chinensis can fall enzyme by heart tonifying.
Embodiment 1:
The prescription that present embodiment adopted is as follows:
Radix Et Rhizoma Rhei 30; Herba Portulacae Grandiflorae 50; Radix Sophorae Flavescentis 50; Herba Artemisiae Scopariae 50; Herba Sedi 100; Herba Hedyotidis Diffusae 100; Herba Abri 100; Kummerowia striata (Thunb.) Schindl 100; Rhizoma Smilacis Glabrae 100; Radix Isatidis 100; Herba Hyperici Japonici 100; Rhizoma Paridis 100; Herba Lysimachiae 100; Hirudo 100; Eupolyphaga 100; Rhizoma Polygoni Cuspidati 50; Radix Cudraniae 100; Herba Silybi mariani 100; Fructus Schisandrae Chinensis 50; Radix Curcumae 50; Radix Glycyrrhizae 50.
The present invention also provides the preparation method of Chinese medicine of above-mentioned treatment hepatitis B as follows:
The crude drug of described parts by weight is mixed pulverizing, make powder.
The using method of the Chinese medicine of treatment hepatitis B provided by the present invention is as follows:
Every day three times, each 5-10 gram.
The technique effect checking that the present invention realized is as follows:
Use treatment by Chinese herbs hepatitis B great three positive HBsAg (+), HBeAg (+) and the immunologic tolerance phase hepatitis B virus duplication person of enlivening clinical case 74 examples of treatment hepatitis B provided by the present invention, 6 examples below 20 years old wherein, 20-50 year 32 examples, patient's 36 examples more than 40 years old, treatment cycle is 6 months, and total effective rate reaches more than 90%.
Use treatment by Chinese herbs hepatitis B small three positive clinical case 35 examples of treatment hepatitis B provided by the present invention, 5 examples below 20 years old wherein, 20-50 year 18 examples, patient's 12 examples more than 40 years old, treatment cycle are 6 months, total effective rate reaches more than 90%.
Embodiment 2:
The prescription that present embodiment adopted is as follows:
Radix Et Rhizoma Rhei 20; Herba Portulacae Grandiflorae 60; Radix Sophorae Flavescentis 40; Herba Artemisiae Scopariae 60; Herba Sedi 80; Herba Hedyotidis Diffusae 110; Herba Abri 80; Kummerowia striata (Thunb.) Schindl 110; Rhizoma Smilacis Glabrae 80; Radix Isatidis 110; Herba Hyperici Japonici 80; Rhizoma Paridis 110; Herba Lysimachiae 80; Hirudo 110; Eupolyphaga 80; Rhizoma Polygoni Cuspidati 60; Radix Cudraniae 80; Herba Silybi mariani 110; Fructus Schisandrae Chinensis 40; Radix Curcumae 60; Radix Glycyrrhizae 40.
The present invention also provides the preparation method of Chinese medicine of above-mentioned treatment hepatitis B as follows:
The crude drug of described parts by weight is mixed pulverizing, make pill.
The using method of the Chinese medicine of treatment hepatitis B provided by the present invention is as follows:
Every day three times, each 5-10 gram.
The technique effect checking that the present invention realized is as follows:
Use treatment by Chinese herbs hepatitis B great three positive HBsAg (+), HBeAg (+) and the immunologic tolerance phase hepatitis B virus duplication person of enlivening clinical case 75 examples of treatment hepatitis B provided by the present invention, 6 examples below 20 years old wherein, 20-50 year 34 examples, patient's 35 examples more than 40 years old, treatment cycle is 6 months, and total effective rate reaches more than 90%.
Use treatment by Chinese herbs hepatitis B small three positive clinical case 34 examples of treatment hepatitis B provided by the present invention, 5 examples below 20 years old wherein, 20-50 year 18 examples, patient's 11 examples more than 40 years old, treatment cycle are 6 months, total effective rate reaches more than 90%.
Embodiment 3:
The prescription that present embodiment adopted is as follows:
Radix Et Rhizoma Rhei 40; Herba Portulacae Grandiflorae 40; Radix Sophorae Flavescentis 60; Herba Artemisiae Scopariae 40; Herba Sedi 110; Herba Hedyotidis Diffusae 80; Herba Abri 110; Kummerowia striata (Thunb.) Schindl 80; Rhizoma Smilacis Glabrae 110; Radix Isatidis 80; Herba Hyperici Japonici 110; Rhizoma Paridis 80; Herba Lysimachiae 110; Hirudo 80; Eupolyphaga 110; Rhizoma Polygoni Cuspidati 40; Radix Cudraniae 110; Herba Silybi mariani 80; Fructus Schisandrae Chinensis 60; Radix Curcumae 40; Radix Glycyrrhizae 60.
The present invention also provides the preparation method of Chinese medicine of above-mentioned treatment hepatitis B as follows:
The crude drug of described parts by weight is mixed pulverizing, make powder.
The using method of the Chinese medicine of treatment hepatitis B provided by the present invention is as follows:
Every day three times, each 5-10 gram.
The technique effect checking that the present invention realized is as follows:
Use treatment by Chinese herbs hepatitis B great three positive HBsAg (+), HBeAg (+) and the immunologic tolerance phase hepatitis B virus duplication person of enlivening clinical case 70 examples of treatment hepatitis B provided by the present invention, 5 examples below 20 years old wherein, 20-50 year 32 examples, patient's 33 examples more than 40 years old, treatment cycle is 6 months, and total effective rate reaches more than 90%.
Use treatment by Chinese herbs hepatitis B small three positive clinical case 33 examples of treatment hepatitis B provided by the present invention, 4 examples below 20 years old wherein, 20-50 year 18 examples, patient's 11 examples more than 40 years old, treatment cycle are 6 months, total effective rate reaches more than 90%.
Embodiment 4:
The prescription that present embodiment adopted is as follows:
Radix Et Rhizoma Rhei 40; Herba Portulacae Grandiflorae 60; Radix Sophorae Flavescentis 40; Herba Artemisiae Scopariae 40; Herba Sedi 110; Herba Hedyotidis Diffusae 110; Herba Abri 80; Kummerowia striata (Thunb.) Schindl 80; Rhizoma Smilacis Glabrae 110; Radix Isatidis 110; Herba Hyperici Japonici 80; Rhizoma Paridis 80; Herba Lysimachiae 110; Hirudo 110; Eupolyphaga 80; Rhizoma Polygoni Cuspidati 40; Radix Cudraniae 110; Herba Silybi mariani 110; Fructus Schisandrae Chinensis 40; Radix Curcumae 40; Radix Glycyrrhizae 40.
The present invention also provides the preparation method of Chinese medicine of above-mentioned treatment hepatitis B as follows:
The crude drug of described parts by weight is mixed pulverizing, make powder.
The using method of the Chinese medicine of treatment hepatitis B provided by the present invention is as follows:
Every day three times, each 5-10 gram.
The technique effect checking that the present invention realized is as follows:
Use treatment by Chinese herbs hepatitis B great three positive HBsAg (+), HBeAg (+) and the immunologic tolerance phase hepatitis B virus duplication person of enlivening clinical case 73 examples of treatment hepatitis B provided by the present invention, 5 examples below 20 years old wherein, 20-50 year 32 examples, patient's 36 examples more than 40 years old, treatment cycle is 6 months, and total effective rate reaches more than 90%.
Use treatment by Chinese herbs hepatitis B small three positive clinical case 34 examples of treatment hepatitis B provided by the present invention, 5 examples below 20 years old wherein, 20-50 year 18 examples, patient's 11 examples more than 40 years old, treatment cycle are 6 months, total effective rate reaches more than 90%.
Claims (3)
1. a Chinese medicine for the treatment of hepatitis B is characterized in that, crude drug and the parts by weight thereof of forming its effective active ingredient are as follows:
Radix Et Rhizoma Rhei 20-40; Herba Portulacae Grandiflorae 40-60; Radix Sophorae Flavescentis 40-60; Herba Artemisiae Scopariae 40-60; Herba Sedi 80-110; Herba Hedyotidis Diffusae 80-110; Herba Abri 80-110; Kummerowia striata (Thunb.) Schindl 80-110; Rhizoma Smilacis Glabrae 80-110; Radix Isatidis 80-110; Herba Hyperici Japonici 80-110; Rhizoma Paridis 80-110; Herba Lysimachiae 80-110; Hirudo 80-110; Eupolyphaga 80-110; Rhizoma Polygoni Cuspidati 40-60; Radix Cudraniae 80-110; Herba Silybi mariani 80-110; Fructus Schisandrae Chinensis 40-60; Radix Curcumae 40-60; Radix Glycyrrhizae 40-60.
2. the Chinese medicine of treatment hepatitis B according to claim 1 is characterized in that, crude drug and the parts by weight thereof of forming its effective active ingredient are as follows:
Radix Et Rhizoma Rhei 30; Herba Portulacae Grandiflorae 50; Radix Sophorae Flavescentis 50; Herba Artemisiae Scopariae 50; Herba Sedi 100; Herba Hedyotidis Diffusae 100; Herba Abri 100; Kummerowia striata (Thunb.) Schindl 100; Rhizoma Smilacis Glabrae 100; Radix Isatidis 100; Herba Hyperici Japonici 100; Rhizoma Paridis 100; Herba Lysimachiae 100; Hirudo 100; Eupolyphaga 100; Rhizoma Polygoni Cuspidati 50; Radix Cudraniae 100; Herba Silybi mariani 100; Fructus Schisandrae Chinensis 50; Radix Curcumae 50; Radix Glycyrrhizae 50.
3. prepare the method for the Chinese medicine of claim 1 or 2 described treatment hepatitis B, as follows:
The crude drug of described parts by weight is mixed pulverizing, make pharmaceutically acceptable pharmaceutical dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101286482A CN100400094C (en) | 2006-09-04 | 2006-09-04 | Traditional Chinese medicine for treating hepatitis B and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101286482A CN100400094C (en) | 2006-09-04 | 2006-09-04 | Traditional Chinese medicine for treating hepatitis B and its preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1927374A CN1927374A (en) | 2007-03-14 |
| CN100400094C true CN100400094C (en) | 2008-07-09 |
Family
ID=37857606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101286482A Expired - Fee Related CN100400094C (en) | 2006-09-04 | 2006-09-04 | Traditional Chinese medicine for treating hepatitis B and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100400094C (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301451B (en) * | 2007-05-11 | 2011-06-15 | 孙学福 | Chinese medicine for treating liver disease |
| CN102068588B (en) * | 2009-11-19 | 2012-09-19 | 夏邦恩 | Chinese medicinal preparation for treating hepatopathy and preparation method thereof |
| CN103156018B (en) * | 2011-12-08 | 2014-03-26 | 许春付 | Original herbal tea capable of soothing liver and dispelling melancholy and preparation method thereof |
| CN102793872B (en) * | 2012-09-05 | 2013-10-23 | 孙绍贵 | Liver treating drink for treating viral hepatitis B |
| CN103007194A (en) * | 2012-11-30 | 2013-04-03 | 汤燕 | Chinese medicine composition for treating hepatitis B |
| CN103405691B (en) * | 2013-04-29 | 2014-11-26 | 刘新江 | Chinese patent medicine pills for treating hepatitis B |
| CN103638451B (en) * | 2013-11-21 | 2016-03-16 | 孙春红 | A kind of Chinese medicine for the treatment of chronic hepatitis and preparation method thereof |
| CN104474397A (en) * | 2014-11-29 | 2015-04-01 | 张莘蔓 | Cudrania cochinchinensis-containing traditional Chinese medicine composition |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1253013A (en) * | 1999-10-25 | 2000-05-17 | 车兴泉 | Medicine for treating hepatism and its preparing process |
| CN1692939A (en) * | 2005-04-09 | 2005-11-09 | 滕立刚 | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method |
| CN1820779A (en) * | 2005-02-16 | 2006-08-23 | 苏明 | Medicinal composition for treating hepatitis B and its preparing method |
-
2006
- 2006-09-04 CN CNB2006101286482A patent/CN100400094C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1253013A (en) * | 1999-10-25 | 2000-05-17 | 车兴泉 | Medicine for treating hepatism and its preparing process |
| CN1820779A (en) * | 2005-02-16 | 2006-08-23 | 苏明 | Medicinal composition for treating hepatitis B and its preparing method |
| CN1692939A (en) * | 2005-04-09 | 2005-11-09 | 滕立刚 | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1927374A (en) | 2007-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101637585B (en) | Chinese herbal preparation for treating posirasis and preparation method thereof | |
| CN100400094C (en) | Traditional Chinese medicine for treating hepatitis B and its preparing process | |
| CN103784820B (en) | For treating Chinese medicine formula and the Chinese medicinal capsule of cardiovascular stasis coronary heart disease | |
| CN103768537B (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN102205059A (en) | Chinese herbal medicine composition for treating liver cancer, stomach cancer, lung cancer and leukemia and preparation method thereof | |
| CN100534506C (en) | Chinese medicinal mixture for treating viral hepatitis | |
| CN103142920A (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN101168027A (en) | Medicine for treating chronic hepatitis B and its preparation method | |
| CN102949659A (en) | Traditional Chinese medicine composition for treating hepatitis B | |
| CN1240415C (en) | Tablets against allergic purpura | |
| CN101912583A (en) | Medicament for treating chronic hepatitis and early-phase hepatocirrhosis and preparation method thereof | |
| CN103006877B (en) | Formula for systemic lupus erythematosus treatment drug | |
| CN1102399C (en) | Antilipemic blood circulation promoting xueluofu capsale | |
| CN1332705C (en) | Chinese medicine for treating liver diseases | |
| CN102018930A (en) | Medicine composition for treating hepatitis B | |
| CN101721582A (en) | Traditional Chinese medicine honeyed pill for treating hepatitis B | |
| CN107320682A (en) | A kind of medicine for treating hepatitis B | |
| CN102949658B (en) | Drug formula for treating hepatitis | |
| CN100441216C (en) | Medicine for treating hepatitis B and its preparation and taking method | |
| CN101062302A (en) | Chinese medicinal preparation for hepatitis B | |
| CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process | |
| CN106377575A (en) | Preparation method and application of Yuganlong granules for treating hepatitis | |
| CN105770188B (en) | liver-protecting traditional Chinese medicine preparation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080709 Termination date: 20100904 |